Energy Focus, Inc. Appoints Laszlo Takacs as Chief Technology Officer
Nov 30, 2017 13:01 pm UTC| Business
SOLON, Ohio, Nov. 30, 2017 -- Energy Focus, Inc. (NASDAQ:EFOI) a leader in energy-efficient LED lighting technologies, today announced the appointment of Laszlo Takacs as its Chief Technology Officer. Mr. Takacs, with...
Nov 30, 2017 13:00 pm UTC| Business
HERNDON, Va., Nov. 30, 2017 -- The U.S. Army has awarded ManTech International Corporation (Nasdaq:MANT) an $847 million task order for Vehicle Engineering Maintenance and Operations Support (VEMOS). This effort was...
Nov 30, 2017 13:00 pm UTC| Business
WASHINGTON, Nov. 30, 2017 -- The National Association of Corporate Directors (NACD), the authority on boardroom practices representing more than 17,000 board members, today released its 2017–2018 NACD Public Company...
BIOLIFE4D Selects FischTank Marketing and PR as Agency of Record
Nov 30, 2017 13:00 pm UTC| Business
CHICAGO, Nov. 30, 2017 -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has retained FischTank Marketing and PR, a New York...
Nov 30, 2017 13:00 pm UTC| Business
NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of First Data...
Nov 30, 2017 13:00 pm UTC| Business
BROKEN ARROW, Okla., Nov. 30, 2017 -- ADDvantage Technologies Group, Inc. (NASDAQ:AEY) announced today that it will release financial results for the three month period and fiscal year ended September 30, 2017, on...
Hooper Holmes Inc. to Present at the LD Micro 10th Annual Main Event on December 5, 2017
Nov 30, 2017 13:00 pm UTC| Business
OLATHE, Kan., Nov. 30, 2017 -- Hooper Holmes, Inc. (OTCQX:HPHW) today announced that, Henry Dubois, Chief Executive Officer, and Mark Clermont, President, will be featured presenters at the LD Micro 10th Annual Main...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update